A new study published in Nature Aging combines mouse experiments and human data sets to explore how biological sex and aging shape cancer immunity, with implications for immunotherapy responses. Lutz ...
The research team engineered CD8+ Jurkat T cells to express SVAR16, a human TCR with intermediate-to-high 2D affinity for the SARS-CoV-2-derived epitope HLAA2:01–YLQ, using lentiviral transduction.
A conference correspondence summarizing 12 clinical and translational abstracts on next-generation CAR-T therapy for ...
A 2026 review finds that TCR-engineered T cells have entered early clinical testing for hepatocellular carcinoma, but safety, antigen heterogeneity and immune suppression remain major barriers.
The Brighterside of News on MSN
MIT scientists create nanoparticles to deliver cancer vaccines tailored to each patient
MIT researchers tuned antigen display on M13 particles to improve tumor protection in mice, advancing a potential platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results